215 related articles for article (PubMed ID: 33526450)
1. Scaffolding Protein IQGAP1 Is Dispensable, but Its Overexpression Promotes Hepatocellular Carcinoma via YAP1 Signaling.
Delgado ER; Erickson HL; Tao J; Monga SP; Duncan AW; Anakk S
Mol Cell Biol; 2021 Mar; 41(4):. PubMed ID: 33526450
[TBL] [Abstract][Full Text] [Related]
2. The Overexpression of IQGAP1 and β-Catenin Is Associated with Tumor Progression in Hepatocellular Carcinoma In Vitro and In Vivo.
Jin X; Liu Y; Liu J; Lu W; Liang Z; Zhang D; Liu G; Zhu H; Xu N; Liang S
PLoS One; 2015; 10(8):e0133770. PubMed ID: 26252773
[TBL] [Abstract][Full Text] [Related]
3. IQGAP1 promotes pancreatic cancer progression and epithelial-mesenchymal transition (EMT) through Wnt/β-catenin signaling.
Hu W; Wang Z; Zhang S; Lu X; Wu J; Yu K; Ji A; Lu W; Wang Z; Wu J; Jiang C
Sci Rep; 2019 May; 9(1):7539. PubMed ID: 31101875
[TBL] [Abstract][Full Text] [Related]
4. Bile acids activate YAP to promote liver carcinogenesis.
Anakk S; Bhosale M; Schmidt VA; Johnson RL; Finegold MJ; Moore DD
Cell Rep; 2013 Nov; 5(4):1060-9. PubMed ID: 24268772
[TBL] [Abstract][Full Text] [Related]
5. Development of hepatocellular carcinoma in Iqgap2-deficient mice is IQGAP1 dependent.
Schmidt VA; Chiariello CS; Capilla E; Miller F; Bahou WF
Mol Cell Biol; 2008 Mar; 28(5):1489-502. PubMed ID: 18180285
[TBL] [Abstract][Full Text] [Related]
6. NUAK2 is a critical YAP target in liver cancer.
Yuan WC; Pepe-Mooney B; Galli GG; Dill MT; Huang HT; Hao M; Wang Y; Liang H; Calogero RA; Camargo FD
Nat Commun; 2018 Nov; 9(1):4834. PubMed ID: 30446657
[TBL] [Abstract][Full Text] [Related]
7. Activation of β-catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice.
Tao J; Calvisi DF; Ranganathan S; Cigliano A; Zhou L; Singh S; Jiang L; Fan B; Terracciano L; Armeanu-Ebinger S; Ribback S; Dombrowski F; Evert M; Chen X; Monga SPS
Gastroenterology; 2014 Sep; 147(3):690-701. PubMed ID: 24837480
[TBL] [Abstract][Full Text] [Related]
8. IQGAP1 Binds to Yes-associated Protein (YAP) and Modulates Its Transcriptional Activity.
Sayedyahossein S; Li Z; Hedman AC; Morgan CJ; Sacks DB
J Biol Chem; 2016 Sep; 291(37):19261-73. PubMed ID: 27440047
[TBL] [Abstract][Full Text] [Related]
9. IQGAP1 gene silencing induces apoptosis and decreases the invasive capacity of human hepatocellular carcinoma cells.
Zoheir KM; Abd-Rabou AA; Harisa GI; Kumar A; Ahmad SF; Ansari MA; Abd-Allah AR
Tumour Biol; 2016 Oct; 37(10):13927-13939. PubMed ID: 27488117
[TBL] [Abstract][Full Text] [Related]
10. A PI3K/AKT Scaffolding Protein, IQ Motif-Containing GTPase Associating Protein 1 (IQGAP1), Promotes Head and Neck Carcinogenesis.
Wei T; Choi S; Buehler D; Anderson RA; Lambert PF
Clin Cancer Res; 2020 Jan; 26(1):301-311. PubMed ID: 31597661
[TBL] [Abstract][Full Text] [Related]
11. Identification of IQ motif-containing GTPase-activating protein 1 as a regulator of long-term ketosis.
Erickson HL; Anakk S
JCI Insight; 2018 Nov; 3(21):. PubMed ID: 30385723
[TBL] [Abstract][Full Text] [Related]
12. IQGAP1 is overexpressed in hepatocellular carcinoma and promotes cell proliferation by Akt activation.
Chen F; Zhu HH; Zhou LF; Wu SS; Wang J; Chen Z
Exp Mol Med; 2010 Jul; 42(7):477-83. PubMed ID: 20530982
[TBL] [Abstract][Full Text] [Related]
13. c-Src promotes the growth and tumorigenesis of hepatocellular carcinoma via the Hippo signaling pathway.
Yang J; Zhang X; Liu L; Yang X; Qian Q; Du B
Life Sci; 2021 Jan; 264():118711. PubMed ID: 33186566
[TBL] [Abstract][Full Text] [Related]
14. YAP Orchestrates Heterotypic Endothelial Cell Communication via HGF/c-MET Signaling in Liver Tumorigenesis.
Thomann S; Weiler SME; Marquard S; Rose F; Ball CR; Tóth M; Wei T; Sticht C; Fritzsche S; Roessler S; De La Torre C; Ryschich E; Ermakova O; Mogler C; Kazdal D; Gretz N; Glimm H; Rempel E; Schirmacher P; Breuhahn K
Cancer Res; 2020 Dec; 80(24):5502-5514. PubMed ID: 33087321
[TBL] [Abstract][Full Text] [Related]
15. SUMOylation of IQGAP1 promotes the development of colorectal cancer.
Liang Z; Yang Y; He Y; Yang P; Wang X; He G; Zhang P; Zhu H; Xu N; Zhao X; Liang S
Cancer Lett; 2017 Dec; 411():90-99. PubMed ID: 28987385
[TBL] [Abstract][Full Text] [Related]
16. TBX3 functions as a tumor suppressor downstream of activated CTNNB1 mutants during hepatocarcinogenesis.
Liang B; Zhou Y; Qian M; Xu M; Wang J; Zhang Y; Song X; Wang H; Lin S; Ren C; Monga SP; Wang B; Evert M; Chen Y; Chen X; Huang Z; Calvisi DF; Chen X
J Hepatol; 2021 Jul; 75(1):120-131. PubMed ID: 33577921
[TBL] [Abstract][Full Text] [Related]
17. CDK9 is dispensable for YAP-driven hepatoblastoma development.
Chen X; Kiss A; Schaff Z; Evert K; Zhang Y; Zhong S; Wang J; Evert M; Calvisi DF; Chen X
Pediatr Blood Cancer; 2020 May; 67(5):e28221. PubMed ID: 32124532
[TBL] [Abstract][Full Text] [Related]
18. Co-activation of PIK3CA and Yap promotes development of hepatocellular and cholangiocellular tumors in mouse and human liver.
Li X; Tao J; Cigliano A; Sini M; Calderaro J; Azoulay D; Wang C; Liu Y; Jiang L; Evert K; Demartis MI; Ribback S; Utpatel K; Dombrowski F; Evert M; Calvisi DF; Chen X
Oncotarget; 2015 Apr; 6(12):10102-15. PubMed ID: 25826091
[TBL] [Abstract][Full Text] [Related]
19. IQGAP1 and IQGAP2 are reciprocally altered in hepatocellular carcinoma.
White CD; Khurana H; Gnatenko DV; Li Z; Odze RD; Sacks DB; Schmidt VA
BMC Gastroenterol; 2010 Oct; 10():125. PubMed ID: 20977743
[TBL] [Abstract][Full Text] [Related]
20. A Therapeutically Targetable TAZ-TEAD2 Pathway Drives the Growth of Hepatocellular Carcinoma via ANLN and KIF23.
Saito Y; Yin D; Kubota N; Wang X; Filliol A; Remotti H; Nair A; Fazlollahi L; Hoshida Y; Tabas I; Wangensteen KJ; Schwabe RF
Gastroenterology; 2023 Jun; 164(7):1279-1292. PubMed ID: 36894036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]